Aurinia Pharmaceuticals's three largest insider shareholders as of March 23, 2026 are Kevin Tang (Director, 12.23Mn shares), Peter Greenleaf (Chief Executive Officer, 1.84Mn shares), Matthew Maxwell Donley (Chief Operating Officer, 680.30K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Kevin Tang | 0 | 12,229,500 | 03 Mar, 2026 | |
| Peter Greenleaf | Chief Executive Officer | 1,840,379 | 0 | 03 Mar, 2026 |
| Matthew Maxwell Donley | Chief Operating Officer | 680,299 | 0 | 03 Mar, 2026 |
| Joseph M Miller | Chief Financial Officer | 576,421 | 0 | 03 Mar, 2026 |
| Stephen P. Robertson | Evp, General Counsel | 505,861 | 0 | 03 Mar, 2026 |
| Scott Michael Habig | Chief Commercial Officer | 456,338 | 0 | 07 Aug, 2024 |
| Volker Knappertz | Evp, Research And Development | 319,128 | 0 | 29 Feb, 2024 |
| Michael Robert Martin | Chief Business Officer | 259,162 | 0 | 06 Mar, 2023 |
| Greg Keenan | Svp, Chief Medical Officer | 154,449 | 0 | 10 Mar, 2026 |
| Neil Solomons | Chief Medical Officer | 90,953 | 0 | 04 Mar, 2022 |
| George M Jr Milne | 78,733 | 0 | 23 May, 2023 | |
| Robert Bindert Huizinga | Evp Of Research | 69,379 | 0 | 04 Mar, 2022 |
| David R.W. Jayne | 56,499 | 0 | 25 Nov, 2024 | |
| Daniel Billen | 28,141 | 0 | 22 May, 2024 | |
| Jill Leversage | 25,053 | 0 | 25 Nov, 2024 | |
| Karen L. Smith | 24,807 | 0 | 25 Nov, 2024 | |
| Jeffrey Allen Bailey | 22,775 | 0 | 24 Nov, 2025 | |
| R. Hector Mackay-Dunn | 18,595 | 0 | 22 May, 2024 | |
| Brinda Balakrishnan | 17,523 | 0 | 22 May, 2024 | |
| Craig A Johnson | 14,592 | 0 | 24 Nov, 2025 | |
| Massimilano Colao | Chief Commercial Officer | 13,495 | 0 | 04 Mar, 2022 |
| Joseph P Hagan | 11,961 | 0 | 23 May, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 06 Mar, 2026 | Greg Keenan | Common Stock | D | 8,069 | $14.32 | 154,449 | D | F |
| 27 Feb, 2026 | Kevin Tang | Common Shares | A | 300,000 | $13.90 | 11,629,500 | I | P |
| 27 Feb, 2026 | Joseph M Miller | Common Stock | A | 57,229 | $0.00 | 613,932 | D | A |
| 27 Feb, 2026 | Peter Greenleaf | Common Stock | A | 196,403 | $0.00 | 1,941,269 | D | A |
| 27 Feb, 2026 | Matthew Maxwell Donley | Common Stock | A | 58,160 | $0.00 | 721,060 | D | A |
| 27 Feb, 2026 | Stephen P. Robertson | Common Stock | A | 59,090 | $0.00 | 542,386 | D | A |
| 27 Feb, 2026 | Greg Keenan | Common Stock | A | 40,586 | $0.00 | 162,518 | D | A |
| 02 Mar, 2026 | Peter Greenleaf | Common Stock | D | 100,890 | $14.21 | 1,840,379 | D | F |
| 27 Feb, 2026 | Kevin Tang | Common Shares | A | 214,839 | $14.12 | 11,844,339 | I | P |
| 02 Mar, 2026 | Stephen P. Robertson | Common Stock | D | 36,525 | $14.21 | 505,861 | D | F |
| 02 Mar, 2026 | Joseph M Miller | Common Stock | D | 37,511 | $14.21 | 576,421 | D | F |
| 02 Mar, 2026 | Matthew Maxwell Donley | Common Stock | D | 40,761 | $14.21 | 680,299 | D | F |
| 27 Feb, 2026 | Greg Keenan | Employee Stock Option (right to buy) | A | 67,870 | $0.00 | 67,870 | D | A |
| 27 Feb, 2026 | Stephen P. Robertson | Employee Stock Option (right to buy) | A | 98,813 | $0.00 | 98,813 | D | A |
| 27 Feb, 2026 | Matthew Maxwell Donley | Employee Stock Option (right to buy) | A | 97,256 | $0.00 | 97,256 | D | A |
| 27 Feb, 2026 | Joseph M Miller | Employee Stock Option (right to buy) | A | 95,700 | $0.00 | 95,700 | D | A |
| 27 Feb, 2026 | Peter Greenleaf | Employee Stock Option (right to buy) | A | 328,424 | $0.00 | 328,424 | D | A |
| 27 Feb, 2026 | Kevin Tang | Common Shares | A | 1,600 | $14.38 | 11,845,939 | I | P |
| 02 Mar, 2026 | Kevin Tang | Common Shares | A | 83,561 | $14.33 | 11,929,500 | I | P |
| 02 Mar, 2026 | Kevin Tang | Common Shares | A | 115,792 | $14.21 | 12,045,292 | I | P |